Brain Health

The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.

Latest News

The findings show that mindfulness training groups could be recommended for those who have residual opioid cravings. | Image Credit: tooratanaubol | stock.adobe.com
Mindfulness Program Reduces Opioid Cravings During Buprenorphine Treatment

February 6th 2025

There were no substantial differences for the mindfulness with substance use or anxiety outcomes compared with the recovery control group.

Multiple sclerosis diagnosis papers -- Image credit: Vitalii Vodolazskyi | stock.adobe.com
Pregnant Individuals With MS More Likely to Experience Mental Illness

February 6th 2025

ADHD written on pill | Image Credit: © Joel bubble ben - stock.adobe.com
ADHD Stimulant Dispensing Decreased Over the Past Decade, Study Finds

February 4th 2025

Elderly woman sleeping -- Image credit: Pixel-Shot | stock.adobe.com
People Who Achieve REM Sleep Later Might Be Experiencing Early Symptom of Alzheimer Disease

February 3rd 2025

The FDA approved meloxicam and rizatriptan (Symbravo; Axsome Therapeutics Inc) for the acute treatment of migraine, either with or without aura | Image Credit: goodluz | stock.adobe.com
FDA Approves Symbravo for Acute Treatment of Migraine With or Without Aura

January 30th 2025

Video Interviews
Podcasts
Pharmacy Times Public Health Matters Podcast (logo)

More News